Quantum BioPharma (QNTM), a biopharmaceutical company focused on innovative biotech solutions, announced that its licensee, Celly Nutrition Corporation, has engaged a leading New York investment bank to raise up to $10 million and explore an initial public offering (IPO) on a major U.S. exchange. Celly Nutrition, the company behind unbuzzd™—a scientifically proven beverage that accelerates […]
Quantum BioPharma (NASDAQ: QNTM) announced compelling results from a clinical trial evaluating its dietary supplement, unbuzzd. The double-blind, randomized, placebo-controlled study demonstrated that unbuzzd significantly accelerates alcohol metabolism, lowers blood alcohol concentration (BAC), and reduces symptoms of intoxication and hangovers. Participants in the trial, aged 21 to 43, experienced a rapid reduction in BAC—more than […]
